NPPB and hydrops fetalis: While NT-Pro BNP has been demonstrated to be an excellent biomarker for chronic HF reflecting severity of the disease and effectiveness of therapy in a number of previous studies, the present study provides strong evidence that neopterin could be another biomarker of diagnosis of HF and improvement of EF and NYHA classification in patients treated with HF reducing drug ivabradine.